About
Brain+ A/S is a Danish health technology company dedicated to improving dementia care through digital solutions. Their mission is to become the leading provider of certified health tech for better dementia management, aiming to support one million people affected by dementia by 2030. The company is known for its innovative approach to Cognitive Stimulation Therapy (CST), which is recognized as a global standard for non-drug treatment of dementia. The flagship product, Ayla – your CST Assistant, is a certified software-based medical device available in the UK and Denmark. It supports clinically validated interventions to help manage cognitive decline in dementia patients. Brain+ has plans for future growth, with a product roadmap that includes new digital dementia solutions aimed at enhancing accessibility and scalability of CST delivery. Targeting individuals affected by dementia, including patients, caregivers, and healthcare providers, Brain+ focuses on creating solutions that facilitate both individual and group therapy settings. Their commitment to clinical validation and market expansion underscores their dedication to improving dementia care.
Technologies
Keywords
Company Information
-
Employees 20
-
Founded 2012
-
Annual Revenue $1097000
Location
53 Kobmagergade, Copenhagen, Capital Region of Denmark, Denmark, 1150